The association between STOPPFall medication use and falls and fractures in community-dwelling older people
Age and Ageing · 2025
DOI: 10.1093/ageing/afaf138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, 2025. Verfasst von Kate Doyle und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Accidental Falls, Independent Living, Fractures, Bone. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Gerontologische Pflege, Sturzprophylaxe
Abstract (Originalsprache)
Introduction
Falls and fractures are common among older people. The Screening Tool of Older Persons Prescriptions in older adults with high fall risk (STOPPFall) provides a comprehensive list of fall-risk-increasing drugs (FRIDs). This study assesses the association between STOPPFall medications and future falls/fractures among a large cohort of community-dwelling people ≥65 years using The Irish Longitudinal Study on Ageing (TILDA) Waves 1–6, collected from 2009 to 2021.
Methods
STOPPFall medications were recorded at Wave 1 and Wave 3. Falls/fractures were self-reported. Logistic regression models reporting odds ratios (ORs) assessed the association between STOPPFall medications and falls (including injurious/unexplained falls) and fractures at follow-up, adjusted for relevant covariates.
Results
Over one in four participants (777/2898, 27%) were prescribed one STOPPFall medication, and 15% (421/2898) were prescribed ≥2 STOPPFall medications. Over half of participants fell during follow-up, with 1/5 sustaining any fracture. Prescription of ≥2 STOPPFall medications was independently associated with all falls [OR 1.67 (95%CI 1.28–2.18); P < 0.001], injurious falls [OR 1.53 (95%CI 1.19–1.97); P = 0.001], unexplained falls [OR 1.86 (95%CI 1.43–2.42); P < 0.001], all fractures [OR 1.59 (95%CI 1.20–2.12); P = 0.001] and hip fractures [OR 1.75 (95%CI 1.00–3.05); P = 0.048]. Increasing prescription of ≥2 STOPPFall medications at Wave 3 was associated with increased likelihood of all falls and injurious falls.
Conclusion
Prescription of ≥2 STOPPFall medications is independently associated with an increased likelihood of all falls and all fractures. This is a potentially modifiable risk factor for falls, and an increased falls risk should be considered when prescribing these medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland.
- Mercer's Institute for Successful Ageing, St James's Hospital, Dublin, Ireland.
- Department of Medical Gerontology, Trinity College Dublin, Dublin, Ireland.
- School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
ORCID-Profile: Kate Doyle, Frank Moriarty, Robert Briggs
Zitieren
APA
Doyle, K., Scarlett, S., Knight, S. P., Moriarty, F., Lavan, A., Kenny, R. A., & Briggs, R. (2025). The association between STOPPFall medication use and falls and fractures in community-dwelling older people. Age and Ageing. https://doi.org/10.1093/ageing/afaf138
Vancouver
Doyle K, Scarlett S, Knight SP, Moriarty F, Lavan A, Kenny RA, et al. The association between STOPPFall medication use and falls and fractures in community-dwelling older people. Age and Ageing. 2025. doi:10.1093/ageing/afaf138
BibTeX
@article{Doyle2025,
author = {Doyle, Kate and Scarlett, Siobhan and Knight, Silvin P and Moriarty, Frank and Lavan, Amanda and Kenny, Rose-Anne and Briggs, Robert},
title = {The association between STOPPFall medication use and falls and fractures in community-dwelling older people},
journal = {Age and Ageing},
year = {2025},
doi = {10.1093/ageing/afaf138}
}
EUVIMED